Literature DB >> 6334462

Persistence of Pneumocystis carinii in lung tissue of acquired immunodeficiency syndrome patients treated for pneumocystis pneumonia.

J H Shelhamer, F P Ognibene, A M Macher, C Tuazon, R Steiss, D Longo, J A Kovacs, M M Parker, C Natanson, H C Lane.   

Abstract

Eleven patients with acquired immunodeficiency syndrome (AIDS) and Pneumocystis carinii pneumonia (PCP) were studied by repeat bronchoscopy during PCP treatment to assess histologic evidence of resolution of the pneumonia. Nine of 10 patients studied after 8 to 21 days of therapy demonstrated evidence of persistent PCP. Four of 6 patients studied after 22 to 35 days of therapy continued to demonstrate Pneumocystis carinii cysts on repeat examination, while only 1 of 4 patients studied after 35 days of therapy showed evidence of PCP pneumonia. The rate of resolution of PCP in patients with AIDS may be different from the rate of resolution of PCP in patients without AIDS. There was no apparent correlation between rate of clinical response and likelihood of histologic resolution on follow-up biopsy. The PCP in patients with AIDS may require more prolonged therapy for complete resolution of this pneumonic process.

Entities:  

Mesh:

Year:  1984        PMID: 6334462     DOI: 10.1164/arrd.1984.130.6.1161

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  16 in total

1.  Clinical and microscopical features of small-intestinal microsporidiosis in patients with AIDS.

Authors:  P Caramello; G Mazzucco; M Romeo; A Ullio; G DeRosa; A Lucchini; B Forno; T Brancale; A Macor; C Preziosi
Journal:  Infection       Date:  1995 Nov-Dec       Impact factor: 3.553

2.  Alteration of the natural history of Pneumocystis carinii infection in patients with acquired immunodeficiency syndrome receiving aerosolized pentamidine.

Authors:  D M Kates; T G Sparling; N Jetha; D R Burdge
Journal:  West J Med       Date:  1991-06

Review 3.  AIDS and the lung. 5--Tests giving an aetiological diagnosis in pulmonary disease in patients infected with the human immunodeficiency virus.

Authors:  R F Miller; T R Leigh; J V Collins; D M Mitchell
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

4.  Techniques for examining Pneumocystis carinii in fresh specimens.

Authors:  J J Ruffolo; M T Cushion; P D Walzer
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

5.  Autopsy findings in AIDS--a histopathological analysis of fifty cases.

Authors:  S Falk; H L Schmidts; H Müller; K Berger; M Schneider; W Schlote; E B Helm; W Stille; K Hübner; H J Stutte
Journal:  Klin Wochenschr       Date:  1987-07-15

Review 6.  Pneumocystis carinii pneumonia.

Authors:  J T Macfarlane; R G Finch
Journal:  Thorax       Date:  1985-08       Impact factor: 9.139

Review 7.  Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia.

Authors:  H F Vöhringer; K Arastéh
Journal:  Clin Pharmacokinet       Date:  1993-05       Impact factor: 6.447

8.  Nucleotide sequence variation in Pneumocystis carinii strains that infect humans.

Authors:  C H Lee; J J Lu; M S Bartlett; M M Durkin; T H Liu; J Wang; B Jiang; J W Smith
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

9.  Prognostic factors of early fatal outcome and long-term survival in patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.

Authors:  A Antinori; G Maiuro; F Pallavicini; F Valente; G Ventura; G Marasca; R Murri; E Pizzigallo; G Camilli; E Tamburrini
Journal:  Eur J Epidemiol       Date:  1993-03       Impact factor: 8.082

10.  Quantitative and qualitative comparison of DNA amplification by PCR with immunofluorescence staining for diagnosis of Pneumocystis carinii pneumonia.

Authors:  T R Leigh; B G Gazzard; A Rowbottom; J V Collins
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.